Colon Cancer Clinical Trial

Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer

Summary

RATIONALE: Gathering information over time from patients who have finished treatment for colorectal cancer may help doctors predict which cancer survivors will improve their physical activity and diet.

PURPOSE: This clinical trial is studying health behaviors in patients who have finished treatment for stage I, stage II, or stage III colorectal cancer.

View Full Description

Full Description

OBJECTIVES:

Primary

To characterize patterns and identify predictors of post-treatment physical activity and dietary changes made by colorectal cancer survivors.

Secondary

To identify the affective and cognitive effects of post-treatment physical activity and dietary changes in these patients.
To identify these patients' preferences regarding diet and physical activity health promotion programs.

OUTLINE: This is a multicenter study.

Patients complete surveys at baseline and at 3 and 6 months. A randomly selected subset of 84 patients also receive an activity monitor to be use at each of the 3 time points. The acceptability of their use is assessed and whether activity levels change across the 3 time points and the extent to which they are convergent with self-reported physical activity are examined.

During each survey, questionnaires are administered to assess the following areas: physical/medical characteristics (self-reported), self-efficacy for physical activity, fruit and vegetable consumption, and dietary fat intake; outcome expectations for physical activity, fruit and vegetable consumption, and dietary fat intake; physical activity and diet behavioral self-regulation; illness representations (causal attributions and controllability of recurrence); perceived risk of colorectal cancer (CRC) recurrence; emotional representations of CRC (cancer-related anxiety and worry about cancer recurrence); healthcare provider recommendations to alter physical activity and dietary intake; social influence from important others; current physical activity and dietary intake; and diet and physical activity program preferences. Patients who received the activity monitor are asked feedback on acceptability of them.

Measures of sociodemographics and disease/treatment characteristics (via medical chart review) are recorded.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Diagnosis of localized or regional colorectal cancer

Stage I, II, or III disease
Completed treatment within the past 6 weeks
No previous diagnosis of colorectal cancer

PATIENT CHARACTERISTICS:

English speaking
No current evidence of neoplastic disease except for nonmelanoma skin cancer
No evidence of severe cognitive impairment

PRIOR CONCURRENT THERAPY:

See Disease Characteristics

Study is for people with:

Colon Cancer

Estimated Enrollment:

222

Study ID:

NCT00966667

Recruitment Status:

Completed

Sponsor:

Rutgers, The State University of New Jersey

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 11 Locations for this study

See Locations Near You

Cooper Hospital/University Medical Center
Camden New Jersey, 08103, United States
JFK Medical Center in Edison
Edison New Jersey, 08818, United States
Centrastate Healthcare System
Freehold New Jersey, 07728, United States
Robert Wood Johnson University Hospital at Hamilton
Hamilton New Jersey, 08690, United States
Mountainside Hospital
Montclair New Jersey, 07042, United States
Morristown Medical Center
Morristown New Jersey, 07962, United States
Jersey Shore University Medical Center
Neptune New Jersey, 07754, United States
Rutgers Cancer Institute of New Jersey
New Brunswick New Jersey, 08903, United States
Saint Peters University Hospital
New Brunswick New Jersey, 08903, United States
University Medical Center at Princeton
Princeton New Jersey, 08540, United States
Robert Wood Johnson University Hospital Somerset
Somerville New Jersey, , United States
Overlook Medical Center
Summit New Jersey, 07901, United States
Fox Chase Cancer Center
Philadelphia Pennsylvania, , United States
MD Anderson Cancer Center
Houston Texas, 77030, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

222

Study ID:

NCT00966667

Recruitment Status:

Completed

Sponsor:


Rutgers, The State University of New Jersey

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider